Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Travel Awards - Institute Community Support

Direct Payment

$1,000.00

Genetic investigation of the Chr X-linked Granulosa cell tumour susceptibility 6 (Gct6) locus, an ovarian tumour suppressor locus in female mice

EF 2013-14

Résumé
My research plan contributes to a CIHR-funded project that uses a defined mouse model of pediatric ovarian cancer to identify an ovarian tumour suppressor within a mapped locus called Granulsa cell tumour susceptibility 6 (Gct6). Traditional genetic mapping strategies in mice have already refined the Gct6 locus to a 1.01 million base pair region of Chr X. It is my project goal to perform informatics analysis with a DNA sequencing data set generated with modern (Next Generation) sequencing technology. The ultimate goal is to identify all potential tumour suppressor gene candidates based on sequence differences between tumour-susceptible (SWR, SJL) and tumour-resistant (Castaneus) mouse strains. In addition to this computational genetics approach, I am involved in a functional test with tumour-susceptible female mice to determine if the Gct6 locus of the most common laboratory mouse strain -C57BL/6- represents a tumour suppressor allele for Gct6. If the answer to the functional test is "yes", the informatics analysis will be simplified, to limit my search for sequence differences that should be in common between C57BL/6 and Castaneus genomes. The ultimate goal of this research is translational; to describe a pathway for pediatric ovarian tumour development in a mouse model that can be further investigated in human cases of juvenile-type granulosa cell tumours.
Programme
Travel Awards - Institute Community Support
Bénéficiaire
Emplacement
Newfoundland and Labrador, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
294325
Name
Rabie Zoha
Region
Newfoundland and Labrador
Country
Canada
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Institute of Cancer Research
Projecttitle
Genetic investigation of the Chr X-linked Granulosa cell tumour susceptibility 6 (Gct6) locus, an ovarian tumour suppressor locus in female mice
Programtype2
Undefined
Orgnameinp2
Direct Payment
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Dhea Capsules; Genotyping; Haplotype Maps; Informatic Data Analysis; Juvenile Granulosa Cell Tumor; Mouse Model; Next Generation Sequencing; Ovarian Cancer; Tumor Susceptibility Allele (Sumor Suppressor Gene)
Abstract
My research plan contributes to a CIHR-funded project that uses a defined mouse model of pediatric ovarian cancer to identify an ovarian tumour suppressor within a mapped locus called Granulsa cell tumour susceptibility 6 (Gct6). Traditional genetic mapping strategies in mice have already refined the Gct6 locus to a 1.01 million base pair region of Chr X. It is my project goal to perform informatics analysis with a DNA sequencing data set generated with modern (Next Generation) sequencing technology. The ultimate goal is to identify all potential tumour suppressor gene candidates based on sequence differences between tumour-susceptible (SWR, SJL) and tumour-resistant (Castaneus) mouse strains. In addition to this computational genetics approach, I am involved in a functional test with tumour-susceptible female mice to determine if the Gct6 locus of the most common laboratory mouse strain -C57BL/6- represents a tumour suppressor allele for Gct6. If the answer to the functional test is "yes", the informatics analysis will be simplified, to limit my search for sequence differences that should be in common between C57BL/6 and Castaneus genomes. The ultimate goal of this research is translational; to describe a pathway for pediatric ovarian tumour development in a mouse model that can be further investigated in human cases of juvenile-type granulosa cell tumours.
Competitiondate
201309
Approvedterm2
0 yr 3 mths
Pinamesdelim
Rabie, Zoha
Approvedterm
0 an 3 mois
Cihrcontribution2
Inst of Cancer Research~ $1,000~ $0~